Mitsubishi Chemical is taking another step in the restructuring of its Asian methyl methacrylate production network.
Under the transaction schedule previously announced by the company, Mitsubishi Chemical planned to transfer its entire 60% interest in Kaohsiung Monomer Company Limited to China Petrochemical Development Corporation by August 3, 2026. CPDC previously owned the remaining 40% and will assume full control of the Taiwanese producer following the transaction.
KMC is based in Kaohsiung, Taiwan, and has operated since 1976. The company manufactures MMA monomer through the acetone cyanohydrin process and has annual production capacity of approximately 105,000 metric tons.
MMA is a key feedstock for polymethyl methacrylate, coatings, adhesives, cast acrylic sheet, automotive components and electronic materials. Mitsubishi Chemical will remain active in the global MMA industry, but the divestment allows it to concentrate production at more competitive sites and direct resources toward markets with stronger growth potential.
The company identified increasingly intense competition in the Asian MMA market as the central reason for its decision. In particular, large-scale capacity additions in China have changed the region’s supply balance and placed growing pressure on established production assets. Mitsubishi Chemical consequently reviewed the strategic value of continuing to own the Taiwan facility and decided to withdraw from the joint venture.
China’s MMA sector has expanded rapidly in recent years, supported by new plants and a broader mix of production technologies. The additional output has increased domestic self-sufficiency and strengthened China’s ability to supply neighboring Asian markets.
That expansion has created a more difficult environment for established producers in Japan, South Korea and Taiwan. Plants using older technology or operating without strong feedstock and downstream integration can face particular pressure when regional supply rises faster than demand.
For traditional ACH-based facilities, long-term competitiveness depends on feedstock economics, energy costs, by-product management, plant scale and maintenance requirements. When MMA margins narrow, smaller or less integrated assets become more likely candidates for divestment or consolidation.
The transaction should therefore be viewed as more than a change in ownership. It shows how Chinese capacity growth is forcing global MMA producers to reconsider the role of mature Asian manufacturing sites within their international portfolios.
Following the transfer, CPDC will independently control KMC. CPDC is an established Taiwanese petrochemical producer whose existing portfolio includes caprolactam and acrylonitrile. Full ownership may allow the company to coordinate KMC’s raw-material procurement, customer relationships and operating strategy more closely with its broader business.
The transaction does not, by itself, remove 105,000 tonnes of MMA capacity from the market. The manufacturing facility remains in place, and its future output will depend on the new owner’s operating-rate, maintenance and commercial decisions.
The accurate conclusion is therefore that Mitsubishi Chemical is exiting the Taiwan MMA production asset—not that the KMC plant has already been permanently shut down.
Even so, the divestment sends a clear structural signal. Asian MMA producers are moving away from strategies centered mainly on volume and market share and are placing greater emphasis on cost position, integration, logistics and sustainable returns.
Mitsubishi Chemical said it will continue consolidating production at locations where it is relatively more competitive while accelerating its expansion into higher-growth markets.
The next issues for the regional market will be KMC’s operating strategy under full CPDC ownership, the utilization rates of new Chinese facilities, Asian export volumes and demand from PMMA, coatings, adhesives and other downstream sectors.
Mitsubishi Chemical’s withdrawal from the 105,000-tonne Taiwan asset marks another stage in the restructuring of Asia’s MMA industry as Chinese capacity increasingly influences regional investment and production decisions.
